{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicz6p4xsmsgembhvro5wcyg6lfswp5z2xztegnrf63oxildekvhmy",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mfjgfjrxtew2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreih6xwzedq2aixz4xe7j6bovtolt3tpgwzmth224tt57bnnd3d4bvq"
    },
    "mimeType": "image/jpeg",
    "size": 115594
  },
  "path": "/2026/02/23/fda-lobbying-efforts-grow-under-trump-administration/?utm_campaign=rss",
  "publishedAt": "2026-02-23T09:30:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "A STAT Investigation",
    "Business",
    "Health",
    "Insurance",
    "Pharma",
    "Politics",
    "advocacy",
    "biotechnology",
    "Congress",
    "drug development",
    "FDA",
    "HHS",
    "legal",
    "Pharmaceuticals",
    "Policy",
    "STAT+",
    "White House"
  ],
  "textContent": "Lobbyists told STAT they believe the odds of approval go up if a decision can be spun as a win for the Trump administration.",
  "title": "STAT+: Pharma lobbyists focus on a surprising new target: the FDA",
  "updatedAt": "2026-02-23T02:52:24.000Z"
}